Dr. Eric Krauland, PhDPresident and Chief Scientific Officer at AdimabSpeaker
Profile
Dr. Eric Krauland is the Chief Scientific Officer and President of Adimab and has been with the company for 16 years. Dr. Krauland has worked in numerous roles at Adimab since 2007 and was a key contributor in the development of Adimab's platform. He received his PhD in Biological Engineering from the Massachusetts Institute of Technology in 2007 and his BS/MSE in Biomedical Engineering from Johns Hopkins University.
Agenda Sessions
Novel anti-CD3 Heavy chain-only Antibodies for Use in T-cell Engaging Multispecific Therapeutics
, 13:45View Session